Citius Pharmaceuticals Inc vs US Global Jets ETF — how do they compare? Citius Pharmaceuticals Inc trades at $0.53 (market cap $14.64M), while US Global Jets ETF trades at $30.85. The key difference: US Global Jets ETF is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| CTXR | JETS | |
|---|---|---|
Market Cap | $14.64M | — |
Sector | Health | Sector/Thematic |
52-Week High | $1.82 | $33.34 |
52-Week Low | $0.53 | $23.12 |
Enterprise Value | $10.86M | — |
Trailing returns across standard periods
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →JETS provides targeted exposure to the global airline industry, including commercial airlines, aircraft manufacturers, and airport operators. It focuses on major U.S. and international carriers like Delta, United, and American Airlines.
Read more on JETS →